Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{182501,
        author = {JIJI K and MADHUSUDHAN A C and MANOJKUMAR S and AUSTIN ARUL RAJ P J and MANOJ V and GUNA D},
        title = {ASSESSING THE SAFETY PROFILE OF COVID-19 VACCINES IN YOUNG INDIVIDUALS: A POST-VACCINATION ADR STUDY},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {2},
        pages = {2181-2186},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=182501},
        abstract = {The safety of COVID-19 vaccines, particularly in younger populations, is of significant public health interest due to potential adverse drug reactions (ADRs) post-vaccination. While vaccines like Covaxin and Covishield have been crucial in mitigating the spread of the virus, understanding the safety profile among college-aged individuals remains limited. This study aims to assess the safety profile of Covaxin and Covishield in a college population, with a focus on post-vaccination ADRs. Data were collected through a Google Forms survey distributed to college students, focusing on those vaccinated with Covaxin or Covishield. The survey captured demographic information, the type of vaccine received, and any experienced ADRs. Additionally, responses were collected from a small group of students who had not received the vaccine, to explore vaccine hesitancy. The analysis focused on the incidence and severity of ADRs, with specific attention to serious events such as myocarditis, pericarditis, and tachycardia. These study results provide insight to the healthcare providers on the importance of monitoring and reporting ADR associated with the drug.
The objective of this study is to assess the safety profile of COVID-19 vaccines, specifically Covaxin and Covishield, in a college-aged population. By focusing on self-reported ADRs, this research aims to provide insights into the types and frequencies of reactions experienced by young adults following vaccination. Furthermore, the study seeks to address vaccine hesitancy observed among a small group of respondents who have not been vaccinated. Understanding the safety and hesitancy landscape is crucial for guiding public health strategies, particularly in efforts to increase vaccine confidence and improve coverage.},
        keywords = {Adverse Drug Reaction (ADR), COVID-19, Covaxin, Covishield, AEFI},
        month = {July},
        }